BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32279449)

  • 1.
    Masteri Farahani A; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
    Chem Biol Drug Des; 2020 Aug; 96(2):850-860. PubMed ID: 32279449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a New
    Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
    Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary application of micro-SPECT/CT imaging by
    Zhang Y; Meng L; Li B; Tan H; Lin QY; Cheng D; Shi H
    Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.
    Garcia MF; Zhang X; Gallazzi F; Fernandez M; Moreno M; Gambini JP; Porcal W; Cabral P; Quinn TP
    Anticancer Agents Med Chem; 2015; 15(1):122-30. PubMed ID: 25175799
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
    J Biomed Sci; 2018 Feb; 25(1):17. PubMed ID: 29455647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
    Yurt Lambrecht F; Durkan K; Ozgür A; Gündüz C; Avcı CB; Susluer SY
    J Drug Target; 2013 May; 21(4):383-8. PubMed ID: 23301856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the biodistribution of (99m)Tc-HYNIC-Lys3-Bombesin obtained with the EDDA/tricine and NA/tricine as coligands].
    Hernández-Cairo A; Perera-Pintado A; Prats-Capote A; Batista-Cuellar JF; Casacó-Santana C
    Rev Esp Med Nucl Imagen Mol; 2012; 31(2):61-5. PubMed ID: 22305264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved
    Khodadust F; Ahmadpour S; Aligholikhamseh N; Abedi SM; Hosseinimehr SJ
    Eur J Med Chem; 2018 Jan; 144():767-773. PubMed ID: 29291444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricine co-ligand improved the efficacy of
    Shaghaghi Z; Abedi SM; Hosseinimehr SJ
    Biomed Pharmacother; 2018 Aug; 104():325-331. PubMed ID: 29775901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
    Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
    Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.
    Yang X; Li G; Ruan C; Hu K; Tang G
    Bioconjug Chem; 2023 Nov; 34(11):2133-2143. PubMed ID: 37874952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of
    Gan Q; Song X; Zhang X; Zhang J
    Eur J Med Chem; 2020 Feb; 188():112032. PubMed ID: 31926467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative assessment of a
    Torabizadeh SA; Abedi SM; Noaparast Z; Hosseinimehr SJ
    Bioorg Med Chem; 2017 May; 25(9):2583-2592. PubMed ID: 28351606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.
    von Guggenberg E; Dietrich H; Skvortsova I; Gabriel M; Virgolini IJ; Decristoforo C
    Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1209-18. PubMed ID: 17308920
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
    Anticancer Agents Med Chem; 2018; 18(9):1295-1302. PubMed ID: 29521248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [
    Mazaheri Tehrani M; Erfani M; Amirmozafari N
    Chem Biol Drug Des; 2021 Apr; 97(4):904-913. PubMed ID: 33326679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Kaihani S; Sadeghzadeh N; Abediankenari S; Abedi SM
    Ann Nucl Med; 2022 Nov; 36(11):976-985. PubMed ID: 36097232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes.
    Ono M; Arano Y; Mukai T; Saga T; Fujioka Y; Ogawa K; Kawashima H; Konishi J; Saji H
    Bioconjug Chem; 2002; 13(3):491-501. PubMed ID: 12009938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.